Neutrophils in cancer: neutral no more
By S. Coffelt, M. Wellenstein, K. E. Visser. Nature Reviews. Cancer, 2016
1,616 citations recorded by the source corpus.
Subfields: Immunology, Oncology
View Paper: https://www.semanticscholar.org/paper/122f57b7a2d22835ed88184e7a59deeb1ce5aa1d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Oncology
Citations in the corpus
- Exosome-Based Cell-Cell Communication in the Tumor Microenvironment (2018, background): “Indeed, tumors can manipulate neutrophils early in their differentiation process, creating a diverse repertoire of functional polarization states (Fridlender et al., 2009; Coffelt et al., 2016).”
- The microenvironmental landscape of brain tumors (2017, background): “The most abundant granulocyte in humans is the neutrophil, which can comprise up to 70% of total leukocytes in the body (Coffelt et al., 2016).”
- Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives (2021, background): “(TANs) Increasing evidence indicates that tumor-associated neutrophils (TANs), a significant component of the TIME, also exhibit phenotypic heterogeneity and functional versatility [144, 145].”
- Transforming Grown Factor-β Signaling in Immunity and Cancer (2019, positive): “80% of MDSCs display a polymorphonuclear phenotype (PMN-MDSCs) similar to that of neutrophils and can be recognized in flow cytometry analysis by the neutrophil surface marker combination CD11b +Ly6G+ (Coffelt et al., 2016; Gabrilovich, 2017).”
- Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types? (2018, background): “Neutrophils play important and contradictory roles in cancer development, as reflected by several recent reviews (Sionov et al., 2015; Swierczak et al., 2015; Uribe-Querol and Rosales, 2015; Coffelt et al., 2016; Mishalian et al., 2017).”
- Single cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species (2019, background): “Tumor-infiltrating neutrophils have been ascribed both anti- and pro-tumor properties, as well as diverse molecular phenotypes (Coffelt et al., 2016; Engblom et al., 2016).”
- Nanomedicine in cancer therapy (2023, background): “113 Neutrophils possess an inherent capacity to traverse the blood-brain barrier, rendering them a promising means of delivering drugs to treat brain tumors.”